Overall survival with camrelizumab plus famitinib versus camrelizumab alone and investigator's choice of chemotherapy for recurrent or metastatic cervical cancer

已完结 10 由不可二二发布于 2025/9/9 11:26:10

DOI:10.1016/j.ygyno.2024.07.040
作者：Xiaohua Wu , Lingfang Xia , Keqiang Zhang , Ying Tang , Guonan Zhang , Danbo Wang , Hanmei Lou , Naifu Liu , Hongping Zhang , Hongwei Chen , Ke Wang ,
文献类型：期刊论文
补充材料：只需要正文

Elsevier

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierResearch progress on the reaction kinetics mechanism of hydrogen-blended fuel combustion